Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | PRKCA | P17252 | 6/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2238652 | 0.93 | LMNA (0.47) | DGKANAAALMNAPRKCA | |
| SCHEMBL11206235 | 0.91 | PRKCA (0.47) | DGKANAAALMNAPRKCA | |
| SCHEMBL5080113 | 0.78 | NAAA (0.50) | DGKANAAALMNAPRKCAPAM | |
| SCHEMBL5080133 | 0.78 | NAAA (0.50) | DGKANAAALMNAPRKCAPAM | |
| SCHEMBL5081015 | 0.78 | NAAA (0.50) | DGKANAAALMNAPRKCAPAM | |
| SCHEMBL2238546 | 0.78 | NAAA (0.50) | DGKANAAALMNAPRKCAPAM | |
| SCHEMBL5079233 | 0.78 | NAAA (0.50) | DGKANAAALMNAPRKCAPAM | |
| SCHEMBL5079237 | 0.78 | NAAA (0.50) | DGKANAAALMNAPRKCAPAM | |
| SCHEMBL27658988 | 0.78 | PRKCA (0.47) | DGKANAAALMNAPRKCA | |
| SCHEMBL180318 | 0.76 | PRKCA (0.49) | DGKANAAAPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7994330-B2 | Oxidizing p-xylene to terephthalic acid using a catalyst having a dicarboximide skeleton; hydrothermally treating the product with hot water, decomposing and removing catalyst impurities | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20080171881-A1 | Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-07-17 | — | — | US | disclosed |
| EP-1870394-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND METHOD FOR DECOMPOSING COMPOUND HAVING DICARBOXYIMIDE SKELETON | Daicel Chemical Industries, Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171881-A1 | Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton | DHPS, OGDH, MCCC2 | DGKA 948/4885NAAA 483/4885LMNA 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.